Redmile Group LLC 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 8,359,768 9.900% | 1,251,671 (+17.61%) | Filing |
| 2023-02-14 4:19 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 7,108,097 9.900% | 1,427,180 (+25.12%) | Filing |
| 2022-05-09 5:15 pm Purchase | 2022-04-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 5,680,917 8.100% | 5,016,100 (+754.51%) | Filing |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 664,817 1.100% | -3,773,151 (-85.02%) | Filing |
| 2021-02-16 4:07 pm Sale | 2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 4,437,968 7.800% | -271,530 (-5.77%) | Filing |